Amphastar Pharmaceuticals AMPH

---

November 26, 2024

Amphastar Pharmaceuticals: A Financial Overview

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is a specialty pharmaceutical company that focuses on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. The company's products are primarily used in hospital or urgent care clinical settings. Here's a detailed look at Amphastar's financials:

 Revenue

Amphastar Pharmaceuticals has shown consistent revenue growth over the years. For the year ending December 31, 2023, the company reported annual revenue of $644.4 million, representing a 29.14% growth year-over-year. In the most recent quarter ending September 30, 2024, Amphastar reported revenue of $191.21 million, a 5.90% growth compared to the previous quarter. The company's revenue for the trailing twelve months (TTM) is $723.55 million, up 20.33% year-over-year.

Balance Sheet

As of the most recent financial report, Amphastar's balance sheet shows total assets of $1.6 billion. The company has $252.93 million in cash and short-term investments, and  $629.85 million in total debt. Total liabilities stand at $817.50 million, while total shareholder's equity is $727.68 million. The book value per share is $15.04.

P/E Ratio

Amphastar Pharmaceuticals has a price-to-earnings (P/E) ratio of 15.93. This ratio indicates how much investors are willing to pay for each dollar of earnings, reflecting the company's profitability and growth expectations.

 Insider Ownership

Insiders own 27.10% of Amphastar Pharmaceuticals' stock. This high level of insider ownership suggests that the company's management and board of directors have a significant stake in the company's success, aligning their interests with those of shareholders.

Amphastar Pharmaceuticals continues to show strong financial performance and growth potential, making it an interesting player in the pharmaceutical industry.

- [Company Website]

www.amphastar.com
- [NASDAQ AMPH Stock]

www.nasdaq.com/market-activity/stocks/amph

Disclaimer: The content on this website is for informational and educational purposes only. It is not intended as financial advice. The author is not a licensed financial advisor. Readers should do their own research and consult with a licensed financial professional before making any investment decisions.